Chemotherapy for non-small cell lung cancer.

Por Carbone, D. P., Minna, J. D.
Publicado em 1995

Dendritic cells transduced with wild-type p53 gene elicit potent anti-tumour immune responses

Por Ishida, T, Chada, S, Stipanov, M, Nadaf, S, Ciernik, F I, Gabrilovich, D I, Carbone, D P
Publicado em 1999

Restoration of TGF-β signalling reduces tumorigenicity in human lung cancer cells

Por Anumanthan, G, Halder, S K, Osada, H, Takahashi, T, Massion, P P, Carbone, D P, Datta, P K
Publicado em 2005

Nuclear survivin as a biomarker for non-small-cell lung cancer

Por Lu, B, Gonzalez, A, Massion, P P, Shyr, Y, Shaktour, B, Carbone, D P, Hallahan, D E
Publicado em 2004

Serum anti-p53 antibodies in gastric adenocarcinoma patients are associated with poor prognosis, lymph node metastasis and poorly differentiated nuclear grade

Por Wu, C-W, Lin, Y-Y, Chen, G-D, Chi, C-W, Carbone, D P, Chen, J-Y
Publicado em 1999

Insulin-like growth factor I receptor blockade enhances chemotherapy and radiation responses and inhibits tumour growth in human gastric cancer xenografts

Por Min, Y, Adachi, Y, Yamamoto, H, Imsumran, A, Arimura, Y, Endo, T, Hinoda, Y, Lee, C-T, Nadaf, S, Carbone, D P, Imai, K
Publicado em 2005

Comparison of p53 gene mutations in paired primary and metastatic gastric tumor tissues.

Por Kim, J. H., Choi, J. J., Noh, S. H., Roh, J. K., Min, J. S., Youn, J. K., Yoo, N. C., Lim, H. Y., Carbone, D. P., Gazdar, A. F.
Publicado em 1993